Skip to content

Archives of Internal Medicine

ISSN 0003-9926

7 papers in the library · 512 citations · publishing 1965-2006

Papers

Effects of a Randomized Controlled Trial of Transcendental Meditation on Components of the Metabolic Syndrome in Subjects With Coronary Heart Disease

Archives of Internal Medicine June 12, 2006 Maura Paul‐labrador, Donna M. Polk, James H. Dwyer et al. 282 citations

Transcendental meditation, practiced for 16 weeks, improved blood pressure and insulin resistance in patients with stable coronary heart disease compared with health education alone. Systolic blood pressure fell by 3.4 mm Hg in the meditation group while rising 2.8 mm Hg in controls; insulin resistance decreased by 0.75 units in the meditation group versus an increase of 0.52 units in controls. Heart rate variability, a measure of cardiac autonomic tone, also improved modestly. No effect was seen on endothelial function. The findings suggest that transcendental meditation may help manage coronary heart disease risk by modulating the body's response to stress.

Methylenedioxyamphetamine. Clinical description of overdose, death, and review of pharmacology

Archives of Internal Medicine October 1, 1981 David Simpson 55 citations

Methylenedioxyamphetamine, a street drug structurally similar to mescaline and amphetamine, can cause severe toxicity beyond hallucinations. A patient exhibited sympathomimetic effects, coma, seizures, hyperreflexia, and hyperthermia. Despite initial stabilization, uncontrollable hyperthermia, hematologic abnormalities, and coma led to death. Hyperthermia involves both central and peripheral mechanisms, so phentolamine (Regitine) mesylate may be the preferred treatment. The drug is not merely a mild hallucinogen.

Carotid Artery Obstruction Following LSD Capsule Ingestion

Archives of Internal Medicine February 1, 1971 Jack D. Sobel 37 citations

A 14-year-old boy with no prior epilepsy, neurological disease, or head trauma experienced a generalized seizure with eye rolling, clonic and tonic movements, and loss of consciousness after ingesting four LSD capsules. For a month before the seizure, his mother had noted episodes of elation and drowsiness. Physical examination showed mild lethargy, restlessness, blood pressure 102/70 mm Hg, pulse 88 beats per minute, respiratory rate 16 per minute, and temperature 100.6°F. This case suggests that LSD ingestion can trigger seizures and focal neurologic signs even in individuals without previous seizure disorders.

Methylenedioxyamphetamine

Archives of Internal Medicine October 1, 1981 Dennis L. Simpson 36 citations

Methylenedioxyamphetamine, a street drug structurally similar to both mescaline and amphetamine, can cause severe and fatal toxicity, contrary to its reputation as a mild hallucinogen. A patient experienced sympathomimetic effects, coma, seizures, hyperreflexia, and hyperthermia. After initial stabilization, the condition deteriorated with uncontrollable hyperthermia, hematologic abnormalities, and coma leading to death. Because hyperthermia involves both central and peripheral mechanisms, phentolamine mesylate may be the preferred treatment in future cases.

Utopiates—The Use and Users of LSD 25.

Archives of Internal Medicine November 1, 1965 Erwin Di Cyan 35 citations

A historical review of Louis Lewin's book on psychoactive drugs, the text draws a parallel between human attempts to surpass ordinary consciousness through drugs and the myth of Lucifer's fall. It references early Christian theologians Tertullian, Origen, and Duns Scotus, who interpreted Lucifer's aspiration to transcend his created limits as the original sin of pride. The summary describes the book's subject matter—narcotic and stimulating drugs, their use and abuse—and situates it within a philosophical and theological framework about the risks of self-transcendence.

Drugs and Phantasy.

Archives of Internal Medicine September 1, 1966 Erwin Di Cyan 2 citations

The reviewer critiques a chapter that argues detailed first-hand accounts of hallucinogenic experiences, collected under controlled conditions, could help decide whether such experiences should be available as an adjunct to life. The reviewer finds this claim to be a large inductive leap, questioning how accounts from just three students—each given psilocybin, LSD, and Sernyl at separate times—can resolve such a fundamental question, especially after the chapter invokes concepts like control and placebo. The reviewer also notes that only one student requested a drug, further undermining the argument's evidentiary basis.